Q&A: Biosimilars Forum engaged in education and advocacy as market is poised to take off
The Biosimilars Forum’s senior policy advisor, Michael Werner — who is also a partner at the law firm of Holland and Knight — talked with MedCity News about what’s going on with biosimilars.